Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HITCH: Degarelix for Hospitalized Veterans with COVID-19
NCT04397718Phase 2Completed
- Sponsor
- VA Office of Research & Development
- Start
- Jul 2020
- Primary completion
- Jun 2021
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of degarelix in coronavirus disease 2019 (COVID-19), sponsored by VA Office of Research & Development. Started Jul 2020; status: completed.
02
Drugs
degarelix
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04397718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04397718.